2-Pyrrolidone → 1-{5-[4-(3,5-Dicyclopropylpyridin-2-yl)piperazine-1-carbonyl]pyridin-2-yl}pyrrolidin-2-one
Reaction equation
[NH:1]1[CH2:5][CH2:4][CH2:3][C:2]1=[O:6].Br[C:8]1[N:13]=[CH:12][C:11]([C:14]([N:16]2[CH2:21][CH2:20][N:19]([C:22]3[C:27]([CH:28]4[CH2:30][CH2:29]4)=[CH:26][C:25]([CH:31]4[CH2:33][CH2:32]4)=[CH:24][N:23]=3)[CH2:18][CH2:17]2)=[O:15])=[CH:10][CH:9]=1>>[CH:28]1([C:27]2[C:22]([N:19]3[CH2:18][CH2:17][N:16]([C:14]([C:11]4[CH:10]=[CH:9][C:8]([N:1]5[CH2:5][CH2:4][CH2:3][C:2]5=[O:6])=[N:13][CH:12]=4)=[O:15])[CH2:21][CH2:20]3)=[N:23][CH:24]=[C:25]([CH:31]3[CH2:33][CH2:32]3)[CH:26]=2)[CH2:29][CH2:30]1Participants
3
Procedure
Using pyrrolidin-2-one (94 mg) and (6-bromopyridin-3-yl)[4-(3,5-dicyclopropylpyridin-2-yl)piperazin-1-yl]methanone (427 mg) described in Preparation Example 143 and by the reaction and treatment in the same manner as in Example 1, the title compound (210 mg) was obtained.
Workup
- customdescribed in Preparation Example 143 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-2ec1161320e741c391c5e4a368340c64
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…